Skip to Content
Søg Menu

Vaccinating Against Mutated RAS in Multiple Myeloma

At EHA 2024, Hanne Norseth, MD, PhD student, Oslo Myeloma Center, Norway, presents a study that aims to evaluate vaccinating against mutated RAS in multiple myeloma. In this MEDtalk, Hanne Norseth presents the tentative data of the ongoing study.
Hanne Norseth

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Fredrik Hellem Schjesvold

ASH 2024: Viktige funn som kan endre behandlingen av myelomatose

/ Fredrik Schjesvold
ASH24Myelomatose Play the Video 05:37
Muhammad Kashif

Novel Risk Stratification Method for Bone Disease in Multiple Myeloma Patients Minimizes Radiation Exposure and Lowers Economic Burden

/ Muhammad Kashif
AIASH24Myelomatose Play the Video 03:57
Meletios-Athanasios Dimopoulos

Daratumumab Monotherapy Shows Clinical Benefit for Early Intervention for Patients with High-Risk Smoldering Multiple Myeloma

/ Meletios A. Dimopoulos
ASH24Myelomatose Play the Video 03:38
Frida Bugge Askeland

Positive Outcome of Steroid Replacement in Transplant-Ineligible Myeloma

/ Frida Bugge Askeland
ASH24Myelomatose Play the Video 03:10
Fredrik Schjesvold

ASH 2024 Highlights: Early Smouldering Myeloma Treatment and Breakthrough Therapies in Multiple Myeloma Take Center Stage

/ Fredrik Schjesvold
ASH24Myelomatose Play the Video 02:57
Alex Lesokhin

Elranatamab Demonstrates Sustained Efficacy with Reduced Dosing Frequency in Refractory Multiple Myeloma

/ Alexander Lesokhin
ASH24Myelomatose Play the Video 4:45

The Aquila Study Strongly Supports the Benefit of Early Intervention with Daratumumab Monotherapy in Patients with High-Risk Smoldering Multiple Myeloma

/ Jan Andreasen
ASH24Myelomatose
Fredrik Schjesvold

The Trispecific Antibody SAR’257 Discontinued After Phase 1 Findings

/ Fredrik Schjesvold
ASH24Myelomatose Play the Video 03:29

Several Trials Showed Improvements in the Treatment of Multiple Myeloma

/ BestPractice Nordic
EHA24Myelomatose
Back to top